Delivery Order SPE2DB20D3304-SPE2DB25FW8M8
- Not listed
- The Defense Logistics Agency awarded a $5,030.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram quantities, with an ultimate completion date of August 14, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger pharmaceutical supply contract vehicle with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company serves as a critical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,515.44 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for Proctofoam-HC 1%-1% Foam in 10-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a child contract...
- This delivery order, valued at $1,284.42, was awarded on July 24, 2025, to AmerisourceBergen Drug Corp for the supply of Proctofoam-HC 1%-1% foam in a 10-gram formulation. The contract is classified as a non-competitive, firm fixed price delivery order under the Defense Logistics Agency's Medical Supply Chain, with an ultimate completion date of July 25, 2025. The performance location is identified as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,297.29 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in 10-gram units. This competitively awarded, firm fixed-price delivery order was issued on June 10, 2025, with an ultimate completion date of June 11, 2025. The product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation and operates as a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.16 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on April 22, 2025, with an ultimate completion date of April 23, 2025. This competitive, non-set-aside award utilizes firm fixed-price pricing and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,131.59 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram unit on May 21, 2025, with an ultimate completion date of May 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters as a...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,724.56 on September 3, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 4, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,603.16 on July 30, 2025, for the supply of Proctofoam 10GM. This firm fixed price, non-competitive delivery order is set to be completed by July 31, 2025, and falls under a child contract associated with the Defense Logistics Agency's Medical Supply Chain. The place of performance is located in Conshohocken, Pennsylvania, reflecting...
- The Defense Logistics Agency awarded a $2,515.44 delivery order to AmerisourceBergen Drug Corp for PROCTOFOAM-HC 1%-1% Foam (10 grams) with an ultimate completion date of September 12, 2025. This is a firm fixed price delivery order with no set-aside designation, issued on September 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $2,863.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. Awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, this non-set-aside contract represents a small-value medical supply procurement. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW8M8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,681.58 to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam, a topical pharmaceutical product in a 10-gram formulation. This non-competitive delivery order, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a firm fixed price contract. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child contract action, this delivery order is issued under a larger contract vehicle that enables the company to supply pharmaceutical and medical products to support federal healthcare needs. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a comprehensive range of medical commodities to military and veteran healthcare systems, including specialty medications, brand-name and generic drugs, and medical devices across multiple therapeutic domains. The company's contract portfolio with DLA demonstrates its capability to fulfill federal procurement requirements through competitive procurement processes, supporting customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/13/25 |